Financhill
Sell
35

PTLKF Quote, Financials, Valuation and Earnings

Last price:
$0.0104
Seasonality move :
39.58%
Day range:
$0.0104 - $0.0104
52-week range:
$0.0005 - $0.0116
Dividend yield:
0%
P/E ratio:
34.67x
P/S ratio:
1.40x
P/B ratio:
0.41x
Volume:
--
Avg. volume:
--
1-year change:
10.64%
Market cap:
$737.1M
Revenue:
$716.2M
EPS (TTM):
$0.00

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, PT Lippo Karawaci Tbk has -- downside to fair value with a price target of -- per share.

PTLKF vs. S&P 500

  • Over the past 5 trading days, PT Lippo Karawaci Tbk has underperformed the S&P 500 by -0.31% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • PT Lippo Karawaci Tbk does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • PT Lippo Karawaci Tbk has grown year-over-year revenues for 1 quarter straight. In the most recent quarter PT Lippo Karawaci Tbk reported revenues of $143.1M.

Earnings Growth

  • PT Lippo Karawaci Tbk has grown year-over-year earnings for 1 quarter straight. In the most recent quarter PT Lippo Karawaci Tbk reported earnings per share of $0.00.
Enterprise value:
1.2B
EV / Invested capital:
0.49x
Price / LTM sales:
1.40x
EV / EBIT:
28.53x
EV / Revenue:
2.21x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-25.96x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
17.56x
Gross Profit (TTM):
$156.7M
Return On Assets:
1%
Net Income Margin (TTM):
6.27%
Return On Equity:
1.71%
Return On Invested Capital:
1.28%
Operating Margin:
8.6%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $1.1B $861.5M $527M $77.3M $143.1M
Gross Profit $394.9M $318.7M $156.7M $32.7M $41.4M
Operating Income $172.3M $116.7M $40.8M $4.5M $12.3M
EBITDA $257.8M $187.5M $66.2M $12.5M $19.3M
Diluted EPS $0.00 $0.02 $0.00 -$0.00 $0.00
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $2.3B $2B $1.9B $2.4B $1.8B
Total Assets $4.4B $3.4B $3.3B $3.7B $3B
Current Liabilities $768M $566.7M $698.5M $511.4M $405.7M
Total Liabilities $2.8B $2B $1.9B $1.7B $1.1B
Total Equity $1.6B $1.3B $1.3B $2B $1.9B
Total Debt $2B $1.2B $1.2B $686.4M $470.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $80.8M $162.7M -$36.5M -$33.7M -$19.6M
Cash From Investing -$56.3M $554.7M -$5.1M $433.9M -$3.7M
Cash From Financing -$56.1M -$425.5M -$249.9M -$65.7M -$240.4M
Free Cash Flow $39M $96.9M -$44.8M -$36.6M -$21.8M
PTLKF
Sector
Market Cap
$737.1M
$991.9M
Price % of 52-Week High
89.66%
85.05%
Dividend Yield
0%
2.45%
Shareholder Yield
7.91%
3.12%
1-Year Price Total Return
10.64%
-4.5%
Beta (5-Year)
0.402
0.644
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $0.0104
200-day SMA
Sell
Level $0.0104
Bollinger Bands (100)
Sell
Level 0.0105 - 0.0105
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $0.0104
Relative Strength Index (RSI14)
Sell
Level 47.3599
ADX Line
Neutral
Level 1.047
Williams %R
Buy
Level -100
50-day SMA
Sell
Level $0.0104
MACD (12, 26)
Buy
Level 0.0004
25-day Aroon Oscillator
Sell
Level 0
On Balance Volume
Sell
Level -16.5K

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.3112)
Sell
CA Score (Annual)
Level (-0.558)
Sell
Beneish M-Score (Annual)
Level (-2.0906)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-3.7911)
Buy
Piotroski F Score (Annual)
Level (6)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

PT Lippo Karawaci Tbk is a real estate company. It engages in residential developments, lifestyle malls, and healthcare. The firm operates through the following segments: Real Estate Development; Real Estate Management & Services; and Fund Management/Investments. The Real Estate Development segment comprises of urban development and development of facilities and infrastructure, food business and other investments, real estate in large scale integrated development project and its infrastructure development activities. The Real Estate Management & Services segment consists of real estate activities in developing and managing shopping center, health services, hotels, restaurants, town management and water and sewage treatment, recreation center, transportation and maintenance services. The Fund Management/Investments segment comprises activities in management services. The company was founded on October 15, 1990 and is headquartered in Tangerang, Indonesia.

Stock Forecast FAQ

In the current month, PTLKF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PTLKF average analyst price target in the past 3 months is --.

  • Where Will PT Lippo Karawaci Tbk Stock Be In 1 Year?

    According to analysts, the consensus estimate is that PT Lippo Karawaci Tbk share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About PT Lippo Karawaci Tbk?

    Analysts are divided on their view about PT Lippo Karawaci Tbk share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PT Lippo Karawaci Tbk is a Sell and believe this share price will rise from its current level to --.

  • What Is PT Lippo Karawaci Tbk's Price Target?

    The price target for PT Lippo Karawaci Tbk over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is PTLKF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for PT Lippo Karawaci Tbk is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of PTLKF?

    You can purchase shares of PT Lippo Karawaci Tbk via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PT Lippo Karawaci Tbk shares.

  • What Is The PT Lippo Karawaci Tbk Share Price Today?

    PT Lippo Karawaci Tbk was last trading at $0.0104 per share. This represents the most recent stock quote for PT Lippo Karawaci Tbk. Yesterday, PT Lippo Karawaci Tbk closed at $0.0104 per share.

  • How To Buy PT Lippo Karawaci Tbk Stock Online?

    In order to purchase PT Lippo Karawaci Tbk stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
50
TGL alert for Dec 8

Treasure Global, Inc. [TGL] is up 10.06% over the past day.

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 47.05% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 10.4% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock